UroGen’s $58 million Initial Public Offering

Hamburger Evron & Co. represented UroGen on the transaction UroGen Pharma, which is held by Mori Arkin and the Pontifax Fund, has raised 58 million dollars…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Michael Patrini.

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here